Takeda Pharmaceutical Co., LTD et al v. Handa Pharmaceuticals, LLC

Filing 59

STIPULATION AND ORDER ON PAGE LIMITS ON CLAIM CONSTRUCTION BRIEFING. Takeda's opening brief, not to exceed 30 pages, due on 11/4/11; Dfts one joint response, not to exceed 30 pages, filed on 11/23/11; Takeda's reply brief due on 12/14/11, not to exceed 15 pages. Signed by Judge Joseph C. Spero on 10/25/11. (klhS, COURT STAFF) (Filed on 10/25/2011)

1

(All parties and counsel listed on Signature Page)

2
UNITED STATES DISTRICT COURT
NORTHERN DISTRICT OF CALIFORNIA
SAN FRANCISCO DIVISION

3
4
5
6
7

TAKEDA PHARMACEUTICAL CO., LTD.,
TAKEDA PHARMACEUTICALS NORTH
AMERICA, INC., TAKEDA
PHARMACEUTICALS LLC, AND TAKEDA
PHARMACEUTICALS AMERICA, INC.,

v.

9

HANDA PHARMACEUTICALS, LLC,

13
14

TAKEDA PHARMACEUTICAL CO., LTD.,
TAKEDA PHARMACEUTICALS NORTH
AMERICA, INC., TAKEDA
PHARMACEUTICALS LLC, AND TAKEDA
PHARMACEUTICALS AMERICA, INC.,

15

Hon. Joseph C. Spero
Courtroom G, 15th Floor

Case No. 3:11-cv-01609 JCS

Plaintiffs,

16
17

Judge:
Courtroom:

Defendant.

11
12

STIPULATION TO PAGE LIMITS ON CLAIM
CONSTRUCTION BRIEFING; [PROPOSED]
ORDER THEREON

Plaintiffs,

8

10

Case No. 3:11-cv-00840 JCS

v.
ANCHEN PHARMACEUTICALS, INC., AND
TWI PHARMACEUTICALS, INC.,

18
Defendants.
19
20
21
22

TAKEDA PHARMACEUTICAL CO., LTD.,
TAKEDA PHARMACEUTICALS NORTH
AMERICA, INC., TAKEDA
PHARMACEUTICALS LLC, AND TAKEDA
PHARMACEUTICALS AMERICA, INC.,

Case No. 3:11-cv-01610 JCS

Plaintiffs,

23
v.

24
25

IMPAX LABORATORIES, INC.,

26

Defendant.

27
28
STIPULATION TO PAGE LIMITS ON CLAIM
CONSTRUCTION BRIEFING;
[PROPOSED] ORDER THEREON

1

Plaintiffs Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals North

2

America, Inc., Takeda Pharmaceuticals LLC, and Takeda Pharmaceuticals America, Inc.

3

(collectively, “Takeda”), and Defendants Handa Pharmaceuticals, LLC (“Handa”), Anchen

4

Pharmaceuticals, Inc. (“Anchen”), TWi Pharmaceuticals, Inc. (“TWi”), and Impax Laboratories,

5

Inc. (“Impax”) (collectively, “Defendants”), hereby stipulate through their respective attorneys as

6

follows:

7
8
9

WHEREAS, on October 14, 2011, the Court ordered the parties to meet and confer and
submit a proposal on the number of briefs and page limits for the Claim Construction;
WHEREAS, the parties have met and conferred;

10

NOW THEREFORE, IT IS HEREBY STIPULATED that, subject to the Court’s approval, the

11

number of briefs and page limits for Claim Construction shall be as follows:

12

-

Takeda shall file one opening brief, not to exceed 30 pages of text, on November 4, 2011;

13

-

Defendants shall file one joint brief in response, not to exceed 30 pages of text, on

14
15
16

November 23, 2011; and
-

Takeda shall file one reply brief on December 14, 2011. Pursuant to Local Rule 7-4(b),
Takeda presently anticipates filing a reply brief of no more than 15 pages.

17
18

Respectfully Submitted,

19
20
21
22

DATED: October 24, 2011

TAKEDA PHARMACEUTICAL CO., LTD.,
TAKEDA PHARMACEUTICALS NORTH
AMERICA, INC., TAKEDA
PHARMACEUTICALS LLC, AND TAKEDA
PHARMACEUTICALS AMERICA, INC.

23
24
25
26
27
28

By:
/s/ Heather E. Takahashi
Jeffrey I. Weinberger (SBN 056214)
[e-mail]
Ted G. Dane (SBN 143195)
[e-mail]
Heather E. Takahashi (SBN 245845)
[e-mail]
MUNGER, TOLLES & OLSON LLP
2

STIPULATION TO PAGE LIMITS ON CLAIM
CONSTRUCTION BRIEFING;
[PROPOSED] ORDER THEREON

3

355 South Grand Ave., 35th Floor
Los Angeles, CA 90071-1560
Telephone: [phone]
Facsimile: [phone]

4

HANDA PHARMACEUTICALS, LLC

1
2

5
6
7
8
9
10
11
12
13
14
15
16

By:
/s/ Steven A. Maddox
William R. Zimmerman (SBN 195859)
[e-mail]
Steven A. Maddox (pro hac vice)
[e-mail]
KNOBBE, MARTENS, OLSON & BEAR, LLP
1717 Pennsylvania Ave., Ste. 900
Washington, D.C. 20006
Los Angeles, CA 90071-1560
Telephone: [phone]
Facsimile: [phone]
Payson J. LeMeilleur (SBN 205690)
[e-mail]
KNOBBE, MARTENS, OLSON & BEAR, LLP
2040 Main Street, 14th Floor
Irvine, CA 92614
Telephone: [phone]
Facsimile: [phone]

17
18

ANCHEN PHARMACEUTICALS, INC. AND
TWI PHARMACEUTICALS, INC.

19
20
21
22
23
24

By:
/s/ Don J. Mizerk
Don J. Mizerk (SBN 208477)
[e-mail]
HUSCH BLACKWELL LLP
120 S. Riverside Plaza, Suite 2200
Chicago, IL 60606
Telephone: [phone]
Facsimile: [phone]

25
26
27
28
3

STIPULATION TO PAGE LIMITS ON CLAIM
CONSTRUCTION BRIEFING;
[PROPOSED] ORDER THEREON

IMPAX LABORATORIES, INC.

1
2
3

By:
/s/ Eric M. Acker
David C. Doyle (SBN 70690)
[e-mail]
Eric M. Acker (SBN 135805)
[e-mail]
MORRISON & FOERSTER LLP
12531 High Bluff Drive, Suite 100
San Diego, CA 92130-2040
Telephone: [phone]
Facsimile: [phone]

4
5
6
7
8
9

Brian F. McMahon (SBN 235373)
[e-mail]
MORRISON & FOERSTER LLP
555 W 5th St 35th Fl
Los Angeles, CA 90013
Telephone: [phone]
Facsimile: [phone]

10
11
12
13
14

Parisa Jorjani (SBN 203487)
[e-mail]
MORRISON & FOERSTER LLP
425 Market Street
San Francisco, CA 94105-2482
P [phone]
F [phone]

15
16
17
18

Attorneys for Defendant
IMPAX LABORATORIES, INC.

19
20

Filer’s Attestation

21
22

I, Heather Takahashi, am the ECF user whose identification and password are

23

being used to file this STIPULATION TO PAGE LIMITS ON CLAIM

24

CONSTRUCTION BRIEFING In compliance with General Order 45.X.B, I hereby

25

attest that the other above-named signatory concurs in this filing.

26

DATED: October 24, 2011

27

/s/ Heather E. Takahashi

28
4

STIPULATION TO PAGE LIMITS ON CLAIM
CONSTRUCTION BRIEFING;
[PROPOSED] ORDER THEREON

ISTRIC
ES D
TC
AT
T

UNIT
ED

3
4

R NIA

2

10/25
DATED: ___________, 2011

S

PURSUANT TO STIPULATION, IT IS SO ORDERED.

RT
U
O

1

THE HONORABLE JOSEPH C. SPERO
UNITED STATES MAGISTRATE JUDGE
pero
ER

S

A

H

7

seph C.

LI

RT

6

Judge Jo

FO

NO

5

N

F
D IS T IC T O
R

C

8
9

14328274.1

10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
5

STIPULATION TO PAGE LIMITS ON CLAIM
CONSTRUCTION BRIEFING;
[PROPOSED] ORDER THEREON